By activating GLP-1 peptides, these medications affect body weight in many ways, including inhibiting glucagon and stimulating insulin release, and resulting in an average loss of 5% to 15% of body weight sustainable for at least 12 months
Results may vary based on individual metabolism, adherence to the program, and lifestyle choices
That is the part of the trial data the marketing skips
Thats why doctors use special medications
Where we get our semaglutide We are getting semaglutide, the active ingredient in Ozempic and Wegovy, from a compounding pharmacy that is FDA-approved, and sources the semaglutide base (not the salt) from an FDA approved manufacturer that follows current Good Manufacturing Practices (cGMP)
Some 40% of them have looked into education or certifications to better understand the medications, according to the survey results shared with Business Insider